• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Argentina·Healthcare·RICH.BA
Share

Laboratorios Richmond S.A.C.I.F. Stocks

ARS 1620Last Updated 12.06.2026

Issuer Rating

3/7
Performance

Favourable

Risk

Considerable

Recommendation

Sell

Market Cap

ARS 90.44M

ARS 1620
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the development and production of a diverse range of medicinal products. Their extensive portfolio includes antiretroviral treatments for human immunodeficiency virus (HIV), as well as therapies for oncology and oncohematology conditions. The company also supplies various cardiometabolic medications, such as those for blood pressure reduction, cholesterol management, platelet aggregation inhibition, and blood sugar control. Additionally, they produce neurological and psychiatric drugs, covering analgesics, antipsychotics, antidepressants, anti-dementia agents, antiepileptics, hypnotics, and treatments for multiple sclerosis. These pharmaceutical offerings are distributed across Latin America, Africa, Asia, and the Middle East. Founded in 1935, Laboratorios Richmond S.A.C.I.F. is headquartered in Buenos Aires, Argentina.

Company Valuation

Undervalued
6/7

Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 22:31

U.S. and Iran to sign agreement on June 14, Strait of Hormuz to reopen - Trump

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026